Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BUTABARB

BUTABARBITAL SODIUM

Standard Dose
30MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BUTABARB is listed in Drugs@FDA under application 085873 (ANDA).

Marketing status: Discontinued Active ingredient BUTABARBITAL SODIUM Form and strength ELIXIR;ORAL - 30MG/5ML Sponsor ALPHARMA US PHARMS Submission history Latest submission status date: 1991-04-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview BUTABARB is listed in Drugs@FDA under application 085873 (ANDA). Marketing status: Discontinued Active ingredient BUTABARBITAL SODIUM Form and strength ELIXIR;ORAL - 30MG/5ML Sponsor ALPHARMA US PHARMS Submission history Latest submission status date: 1991-04-29 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.